Catheter Precision, Inc. Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent
Catheter Precision, Inc. (VTAK) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent of 0.10% for the 12-month period ending 2024-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense · last filed 2026-03-31
- Catheter Precision, Inc. effective income tax rate reconciliation, nondeductible expense, percent for fiscal 2024 was 0.10%.
- Catheter Precision, Inc. effective income tax rate reconciliation, nondeductible expense, percent for fiscal 2023 was -0.20%.
- Catheter Precision, Inc. effective income tax rate reconciliation, nondeductible expense, percent for fiscal 2020 was 0.10%, a 75.00% decline from fiscal 2019.
- Catheter Precision, Inc. effective income tax rate reconciliation, nondeductible expense, percent for fiscal 2019 was 0.40%, a 80.00% decline from fiscal 2018.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent 12 month | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent 12 month as first filed |
|---|---|---|
| 2024-12-31 | 0.10% 10-K · filed 2026-03-31 | -0.10% 10-K · filed 2025-03-31 |
| 2023-12-31 | -0.20% 10-K · filed 2025-03-31 | |
| 2020-12-31 | 0.10% 10-K · filed 2021-03-17 | |
| 2019-12-31 | 0.40% 10-K · filed 2021-03-17 | |
| 2018-12-31 | 2.00% 10-K · filed 2020-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |